FMOC-S-trityl-L-cysteine; Fmoc-L-Cys(Trt)-OH; N-Fmoc-S-trityl-L-cysteine; Fmoc-Cys(Trt); MFCD00038538; N(alpha)-Fluorenylmethyloxycarbonyl-S-tritylcysteine; CHEMBL396414; N-(9-Fluorenylmethoxycarbonyl)-S-trityl-L-cysteine; (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-tritylsulfanylpropanoic acid; L-Cysteine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-S-(triphenylmethyl)-; Fmoc-S-trityl-cys; N-[(9H-fluoren-9-ylmethoxy)carbonyl]-S-trityl-L-cysteine; (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(tritylthio)propanoic acid; Na-Fmoc-Ng-trityl-L-glutamine; L-Cysteine, N-((9H-fluoren-9-ylmethoxy)carbonyl)-S-(triphenylmethyl)-; Fmoc-Cyc(Trt)-OH; PubChem10010; Fmoc-S-Trityl-Cys-OH; FMOC-L-CYS(TRT); FMOC-L-CYS(TRITYL); KSC176O9R; FMOC-CYSTEINE(TRT)-OH; FMOC-L-CYSTEINE (TRT); N-(9-Fluorenyl methoxy carbonyl)-S-trityl-L-cysteine; SCHEMBL1738641; FMOC-L-CYSTEINE(TRITYL); CTK0H6798; DTXSID70145699; KS-00000AD0; STR09764; ZINC4284046; ANW-14816; BBL103590; BDBM50213734; N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-S-(triphenylmethyl)-L-cysteine; STL557400; AKOS015924131; AM81677; CS-W007798; MCULE-1796690263; AC-10507; AC-12310; SC-00132; AB0012529; DB-029846; F0652; M03395; 213F327; N-9-Fluorenylmethyloxycarbonyl-S-trityl-L-cysteine; J-300088; N-(alpha)-fluorenylmethyloxycarbonyl-S-tritylcysteine; N-alpha-(9-Fluorenylmethoxycarbonyl)-S-trityl-L-cysteine; Nalpha-(9-Fluorenylmethoxycarbonyl)-S-trityl-L-cysteine; Fmoc-Cys(Trt)-OH, >=95.0% (sum of enantiomers, HPLC); N-alpha-(9-Fluorenylmethyloxycarbonyl)-S-trityl-L-cysteine; (R)-2-(((9H-fluoren-9-yl)methoxy)carbonyl)-3-(tritylthio)propanoic acid; 2(R)-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-tritylsulfanyl-propionic acid